Abstract |
Alzheimer's disease (AD) is the most common form of dementia and is characterized by neuropathological hallmarks consisting of accumulation of extracellular amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles (NFT). Recently, we have identified a new AD therapeutic candidate, ethyl-8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[ cyclopentane-1,3'-imidazo [1,2-a] pyridin]-2-ene-3-carboxylate (SAK3), which ameliorates the AD-like pathology in AppNL-F/NL-F knock-in mice. However, the detailed mechanism underlying the therapeutic effects of SAK3 remains unclear. In this study, we found that SAK3 administration improved the reduced proteasome activity through the activation of CaMKII/Rpt6 signaling in AppNL-F/NL-F knock-in (NL-G-F) mice. Moreover, spine abnormalities observed in NL-G-F mice were significantly reversed by SAK3 administration. Along with this, cognitive impairments found in NL-G-F mice were markedly ameliorated by SAK3. In summary, our data suggest that SAK3 administration increases the activity of the proteasome via activation of the CaMKII/Rpt6 signaling pathway, contributing to improvements in spine abnormalities and cognitive deficits in NL-G-F mice. Overall, our findings suggest that SAK3 might be a new attractive drug candidate, representing a new mechanism for the treatment of AD pathology.
|
Authors | Hisanao Izumi, Ichiro Kawahata, Yasuharu Shinoda, Fred J Helmstetter, Kohji Fukunaga |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 21
Issue 11
(May 28 2020)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 32481611
(Publication Type: Journal Article)
|
Chemical References |
- APP protein, mouse
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
- Imidazoles
- Psmc5 protein, mouse
- SAK3 compound
- Spiro Compounds
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
- Proteasome Endopeptidase Complex
- ATPases Associated with Diverse Cellular Activities
|
Topics |
- ATPases Associated with Diverse Cellular Activities
(genetics)
- Alzheimer Disease
(metabolism)
- Amyloid beta-Peptides
(metabolism)
- Amyloid beta-Protein Precursor
(genetics)
- Animals
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
(genetics)
- Cognitive Dysfunction
(drug therapy, metabolism)
- Dendritic Spines
(metabolism)
- Female
- Gene Knock-In Techniques
- Imidazoles
(pharmacology)
- Liver
(metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Neurofibrillary Tangles
(metabolism)
- Phosphorylation
- Plaque, Amyloid
(metabolism)
- Proteasome Endopeptidase Complex
(genetics, metabolism)
- Signal Transduction
- Spine
(pathology)
- Spiro Compounds
(pharmacology)
|